SPONSOR
Dana-Farber Cancer Institute
Total Trials
11
Recruiting
11
Phases
EARLY_Phase 1, Phase 1, Phase 2
Conditions studied: Pancreatic CancerPancreatic Ductal AdenocarcinomaPDACPDAC - Pancreatic Ductal AdenocarcinomaPancreatic NeoplasmAcute Myeloid LeukemiaAcute Myeloid Leukemia RecurrentLeukemiaLeukemia, MyeloidChemotherapy Induced Peripheral Neuropathy (CIPN)
Dana-Farber Cancer Institute is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Dana-Farber Cancer Institute
How many clinical trials has Dana-Farber Cancer Institute sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Dana-Farber Cancer Institute, of which 11 are actively recruiting participants. These trials cover conditions including Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Dana-Farber Cancer Institute research focus on?
Dana-Farber Cancer Institute clinical trials span Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasm, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Dana-Farber Cancer Institute clinical trial?
To participate in a Dana-Farber Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Dana-Farber Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Dana-Farber Cancer Institute
NCT06122896 EARLY_Phase 1
Recruiting
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Pancreatic Cancer
NCT06152809 Phase 1
Recruiting
CIML NK Cells With Venetoclax for AML
Acute Myeloid Leukemia
NCT06807294
Recruiting
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Chemotherapy Induced Peripheral Neuropathy (CIPN)
NCT06283251
Recruiting
PediRISE Feasibility
Pediatric Cancer
NCT06038318
Recruiting
Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer
Stress
NCT04541654
Recruiting
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
Li-Fraumeni Syndrome
NCT05327465
Recruiting
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Androgen Deprivation Therapy
NCT06026111
Recruiting
Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE Trial
Lung Cancer
NCT04636710
Recruiting
Refining Local-Regional Therapy for IBC
Breast Cancer
NCT06609473
Recruiting
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
Childhood Cancer
NCT04893109 Phase 2
Recruiting
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology